Essex Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Essex Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-25,963	Closed	-$1.86M	–	441
2022 Q2	$1.86M	Sell	25,963 -3,574	-12%	-$261K	0.3%	103
2022 Q1	$2.39M	Buy	29,537 +2	+0%	+$169	0.3%	100
2021 Q4	$3.03M	Sell	29,535 -684	-2%	-$65.7K	0.35%	87
2021 Q3	$2.64M	Sell	30,219 -671	-2%	-$60.7K	0.32%	98
2021 Q2	$2.76M	Sell	30,890 -7,411	-19%	-$626K	0.32%	103
2021 Q1	$2.9M	Buy	38,301 +34,633	+944%	+$2.61M	0.35%	92
2020 Q4	$250K	Buy	+3,668	New	+$229K	0.03%	337
2016 Q2	–	Sell	-11,237	Closed	-$463K	–	345
2016 Q1	$463K	Buy	+11,237	New	+$463K	0.08%	239

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Essex Investment Management's SYNH Position: Q3 2022 in Review

Essex Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 25,963 shares — an estimated $1.86M sold.

Essex Investment Management first reported a position in SYNH in Q1 2016 and held it in 8 quarters. The position peaked at $3.03M in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Essex Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Essex Investment Management sold 25,963 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $1.86M.
Essex Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 8 quarters.
Essex Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $3.03M in Q4 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Essex Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.